Deciphering the Gut-Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease

被引：0
|
作者：
Singh, Samradhi [1 ]
Kriti, Mona [1 ]
Catanzaro, Roberto [2 ]
Marotta, Francesco [3 ]
Malvi, Mustafa [4 ]
Jain, Ajay [4 ]
Verma, Vinod [5 ]
Nagpal, Ravinder [6 ]
Tiwari, Rajnarayan [1 ]
Kumar, Manoj [1 ]
机构：
[1] ICMR Natl Inst Res Environm Hlth, Bhopal Bypass Rd, Bhopal 462030, India
[2] Univ Catania, Univ Hosp Policlin G Rodol, Dept Clin & Expt Med, Internal Med Unit,Gastroenterol & Hepatol Serv, I-95123 Catania, Italy
[3] ReGenera Res Grp Aging Intervent, I-20144 Milan, Italy
[4] Choithram Hosp & Res Ctr Indore, Indore 452014, India
[5] Sanjay Gandhi Postgrad Inst Med Sci, Stem Cell Res Ctr, Dept Hematol, Lucknow 226014, India
[6] Florida State Univ, Coll Hlth & Human Sci, Dept Nutr & Integrat Physiol, Tallahassee, FL 32306 USA
来源：
LIVERS | 2024年 / 4卷 / 03期
关键词：
metabolic disorder; NAFLD; gut-liver axis; gut microbiome; hepatic steatosis; probiotics; ANTIBIOTIC-ASSOCIATED DIARRHEA; INTESTINAL PERMEABILITY; ADIPOSE-TISSUE; OBESE MICE; BILE-ACIDS; MICROBIOTA; PROBIOTICS; CHILDREN; HEALTH; INFLAMMATION;
D O I：
10.3390/livers4030032
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Non-alcoholic fatty liver disease (NAFLD) has emerged as a significant global health issue. The condition is closely linked to metabolic dysfunctions such as obesity and type 2 diabetes. The gut-liver axis, a bidirectional communication pathway between the liver and the gut, plays a crucial role in the pathogenesis of NAFLD. This review delves into the mechanisms underlying the gut-liver axis, exploring the influence of gut microbiota, intestinal permeability, and inflammatory pathways. This review also explores the potential therapeutic strategies centered on modulating gut microbiota such as fecal microbiota transplantation; phage therapy; and the use of specific probiotics, prebiotics, and postbiotics in managing NAFLD. By understanding these interactions, we can better comprehend the development and advancement of NAFLD and identify potential therapeutic targets.
引用
收藏
页码：435 / 454
页数：20
相关论文
共 50 条
  • [1] Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
    Poeta, Marco
    Pierri, Luca
    Vajro, Pietro
    CHILDREN-BASEL, 2017, 4 (08):
  • [2] Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
    Paolella, Giulia
    Mandato, Claudia
    Pierri, Luca
    Poeta, Marco
    Di Stasi, Martina
    Vajro, Pietro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15518 - 15531
  • [3] Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
    Giulia Paolella
    Claudia Mandato
    Luca Pierri
    Marco Poeta
    Martina Di Stasi
    Pietro Vajro
    World Journal of Gastroenterology, 2014, 20 (42) : 15518 - 15531
  • [4] Gut-liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
    Compare, D.
    Coccoli, P.
    Rocco, A.
    Nardone, O. M.
    De Maria, S.
    Carteni, M.
    Nardone, G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (06) : 471 - 476
  • [5] Intestinal Permeability in Non-alcoholic Fatty LIVER Disease: The Gut-liver Axis
    Scarpellini, E.
    Lupo, M.
    Iegri, C.
    Gasbarrini, A.
    De Santis, A.
    Tack, J.
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (03) : 141 - 147
  • [6] Gut-liver axis, nutrition, and non-alcoholic fatty liver disease
    Kirpich, Irina A.
    Marsano, Luis S.
    McClain, Craig J.
    CLINICAL BIOCHEMISTRY, 2015, 48 (13-14) : 923 - 930
  • [7] Deciphering the role of gut metabolites in non-alcoholic fatty liver disease
    Ralli, Tanya
    Saifi, Zoya
    Tyagi, Neha
    Vidyadhari, Arya
    Aeri, Vidhu
    Kohli, Kanchan
    CRITICAL REVIEWS IN MICROBIOLOGY, 2023, 49 (06) : 815 - 833
  • [8] Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut-Liver Axis
    Chen, Xiang
    Liu, Menghan
    Tang, Jun
    Wang, Ning
    Feng, Yibin
    Ma, Haotian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [9] Gut-Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
    Pezzino, Salvatore
    Sofia, Maria
    Faletra, Gloria
    Mazzone, Chiara
    Litrico, Giorgia
    La Greca, Gaetano
    Latteri, Saverio
    BIOLOGY-BASEL, 2022, 11 (11):
  • [10] Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease
    Castelnuovo, Gabriele
    Perez-Diaz-Del-Campo, Nuria
    Guariglia, Marta
    Poggiolini, Irene
    Armandi, Angelo
    Rosso, Chiara
    Caviglia, Gian P.
    Bugianesi, Elisabetta
    MINERVA GASTROENTEROLOGY, 2024, 70 (04): : 446 - 453
12345